Product Orders. During the Term, Baxter shall supply Client with the quantity of Product ordered by Client, unless the quantity for any three month period exceeds ***percent (***%) of the Rolling Forecast for such three month period, in which event Baxter shall use good faith efforts to supply quantities in excess of ***percent (***%) of the Forecast for such three month period. In no event shall Client order and purchase in any such three month period less than *** percent (***%) of the Rolling Forecast for such three month period (the “Minimum Quantity”). Client agrees to use good faith efforts to evenly distribute such quantities across each twelve (12) month period. ***. Notwithstanding the foregoing, in any Contract Year or as applicable any renewal term, Baxter shall not be obligated to Produce more than the quantity of Product set forth in Exhibit B as B▇▇▇▇▇’▇ Supply Obligation.
Appears in 1 contract
Sources: Commercial Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)
Product Orders. During the Term, Baxter shall supply Client with the quantity of Commercial Product ordered by Client, unless the quantity for any three month period exceeds ***percent (***%) of the Rolling Forecast for such three month period, in which event Baxter shall use good faith efforts to supply quantities in excess of ***percent (***%) of the Forecast for such three month period. In no event shall Client order and purchase in any such three month period less than *** *percent (***%) of the Rolling Forecast for such three month period (the “Minimum Quantity”). Client agrees to use good faith efforts to evenly distribute such quantities across each twelve (12) month period. ***. Notwithstanding the foregoing, in any Contract Year or as applicable any renewal term, Baxter shall not be obligated to Produce more than the quantity of Commercial Product set forth in Exhibit B the applicable Commercial Product Addendum as B▇▇▇▇▇▇’▇ Supply Obligation.
Appears in 1 contract
Sources: Master Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)
Product Orders. During the Term, Baxter shall supply Client with the quantity of Product ordered by Client, unless the quantity for any three month period exceeds ***percent (***%) of the Rolling Forecast for such three month period, in which event Baxter shall use good faith efforts to supply quantities in excess of ***percent (**** %) of the Forecast for such three month period. In no event shall Client order and purchase in any such three month period less than *** percent (**** %) of the Rolling Forecast for such three month period (the “Minimum Quantity”). Client agrees to use good faith efforts to evenly distribute such quantities across each twelve (12) month period. ***. Notwithstanding the foregoing, in any Contract Year or as applicable any renewal term, Baxter shall not be obligated to Produce more than the quantity of Product set forth in Exhibit B as B▇▇▇▇▇’▇ Supply Obligation.
Appears in 1 contract
Sources: Commercial Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)
Product Orders. During the Term, Baxter shall supply Client with the quantity of Commercial Product ordered by Client, unless the quantity for any three month period exceeds ***percent (***%) of the Rolling Forecast for such three month period, in which event Baxter shall use good faith efforts to supply quantities in excess of ***percent (***%) of the Forecast for such three month period. In no event shall Client order and purchase in any such three month period less than *** *percent (***%) of the Rolling Forecast for such three month period (the “Minimum Quantity”). Client agrees to use good faith efforts to evenly distribute such quantities across each twelve (12) month period. ***. Notwithstanding the foregoing, in any Contract Year or as applicable any renewal term, Baxter shall not be obligated to Produce more than the quantity of Commercial Product set forth in Exhibit B the applicable Commercial Product Addendum as B▇▇▇▇▇’▇ Supply Obligation.
Appears in 1 contract
Sources: Master Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)